Coagulation factor XIII B subunit antigen, FXIIIVa134Leu genotype and ischemic stroke in South Asians [5]

Thrombosis and Haemostasis

Volumn 93, Issue 2, 2005, Pages 394-395

  Kain, Kirti ^a   Young, John ^a   Bavington, John ^a   Bamford, John ^a   Catto, Andrew J ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 13A; BLOOD CLOTTING FACTOR 13B; FIBRINOGEN; HIGH DENSITY LIPOPROTEIN; INSULIN; LEUCINE; TRIACYLGLYCEROL; VALINE;

ATHEROSCLEROSIS; BLOOD CLOTTING TEST; BLOOD SAMPLING; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CHEMICAL ANALYSIS; COMPARATIVE STUDY; CORRELATION FUNCTION; DISEASE ASSOCIATION; DNA POLYMORPHISM; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBRINOLYSIS; GENOTYPE; HIGH RISK POPULATION; HUMAN; INSULIN RESISTANCE; LETTER; LOGISTIC REGRESSION ANALYSIS; MORTALITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK FACTOR; SOUTH ASIA; STATISTICAL SIGNIFICANCE; THROMBOSIS; WORLD HEALTH ORGANIZATION;

EID: 13844296536     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1616249     Document Type: Letter

References (12)

1. Mansfield MW, Kohler HP, Ariens RA, et al. Circulating levels of coagulation factor XIII in subjects with type 2 diabetes and in their first-degree relatives. Diabetes Care 2000; 23: 703-5.
2. Warner D, Mansfield MW, Grant PJ. Coagulation factor XIII and cardiovascular disease in UK Asian patients undergoing coronary angiography. Thromb Haemost 2001; 85: 408-11.
3. Kain K, Catto AJ, Young J, et al. Increased fibrinogen, von Willebrand factor and tissue plasminogen activator levels in insulin resistant South Asian patients with ischaemic stroke. Atherosclerosis 2002; 163: 371-6.
4. Catto AJ, Kohler HP, Coore J, et al. Association of a common polymorphism in the factor XIII gene with venous thrombosis. Blood 1999; 93: 906-8.
5. Pyorala M, Miettinen H, Halonen P, et al. Insulin resistance syndrome predicts the risk of coronary heart disease and stroke in healthy middle-aged men: the 22-year follow-up results of the Helsinki Policemen Study. Arterioscler Thromb Vasc Biol 1999; 20: 538-44.
6. Kain K, Catto AJ, Grant PJ. Clustering of thrombotic factors with insulin resistance in South asian patients with ischaemic stroke. Thromb Haemost 2002; 88: 950-3.
7. Reiner AP, Frank MB, Schwartz SM, et al. Coagulation factor XIII polymorphisms and the risk of myocardial infarction and ischaemic stroke in young women. Br J Haematol 2002; 116: 376-82.
8. Endler G, Funk M, Haering D, et al. Is the factor XIII 34Val/Leu polymorphism a protective factor for cerebrovascular disease? Br J Haematol 2003; 120: 310-4.
9. Corral J, Gonzalez-Conejero R, Iniesta JA, et al. The FXIII Val34Leu polymorphism in venous and arterial thromboembolism. Haematologica 2000; 85: 293-7.
10. Gemmati D, Serino ML, Ongaro A, et al. A common mutation in the gene for coagulation factor XIII-A (VAL34Leu): a risk factor for primary intracerebral hemorrhage is protective against atherothrombotic diseases. Am J Hematol 2001; 67: 183-8.
11. Kohler HP, Stickland MH, Ossei-Gerning N, et al. Association of a common polymorphism in the factor XIII gene with myocardial infarction. Thromb Haemost 1998; 79: 8-13.
12. Elbaz A, Poirier O, Canaple S, et al. The association between the Val34Leu polymorphism in the factor XIII gene and brain infarction. Blood 2000; 95: 586-91.